跳至主要内容
临床试验/NCT05437003
NCT05437003已完成不适用

A Cross-Sectional Study to Evaluate the Correlation Between Oculometric Measures and MDS-UPDRS in Patients With Idiopathic Parkinson's Disease (PD) and Evaluation of Oculometric Measures in Healthy Participants

NeuraLight2 个研究点 分布在 1 个国家目标入组 465 人开始时间: 2022年8月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
NeuraLight
入组人数
465
试验地点
2
主要终点
Correlation between MDS-UPDRS score and its parts with NeuraLight oculometric measurements

研究概览

简要总结

This is a prospective study in a cohort of about 500 patients with Idiopathic Parkinson's disease, examined routinely in the neurological outpatient clinic.

This study aims to evaluate the correlation between oculometric measures and clinical endpoints. Subjects will be evaluated following a physician examination.The evaluations will include MDS-UPDRS examination, as well as an oculometric evaluation for eye movements. In addition, 500 healthy subjects will be evaluated.

详细描述

This is a prospective study in a cohort of patients with idiopathic PD who are visiting the Parkinson's outpatient clinic. The aim of the study is to evaluate the correlation between oculometric measures and MDS-UPDRS score in subjects who meet the inclusion criteria and who provide a signed Informed Consent.

This study is designed to evaluate the correlation between oculometric measures and the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Subjects will be evaluated at their visit to the clinic. The evaluations will include an MDS-UPDRS examination by a certified neurologist and other tests. In addition, all patients will undergo a NeuraLight session for oculometric evaluation along with eye-tracking recordings. All assessments will be performed during a clinic visit unless authorized to be conducted remotely. In addition, 500 healthy subjects will be evaluated, undergoing a NeuraLight session for oculometric evaluation along with eye-tracking recordings.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • PD patients:
  • Inclusion Criteria:
  • Men and women with idiopathic PD (Hoehn & Yahr scale 1-5)
  • Age between 18 and 85 years old
  • Normal or corrected vision
  • Ability to follow instructions
  • Willing and able to sign an informed consent form

排除标准

  • Inability to sit for 20 minutes on a chair in a calm manner
  • Personal or 1st degree relative history of epilepsy
  • Additional neurological diseases
  • Drug or alcohol abuse
  • Healthy subjects:
  • Inclusion Criteria:
  • Age between 18 and 85 years old
  • Normal or corrected vision
  • Ability to follow instructions
  • Willing and able to sign an informed consent form
  • Exclusion Criteria
  • Inability to sit for 20 minutes on a chair in a calm manner
  • Personal or 1st degree relative history of epilepsy
  • Neurological diseases
  • Drug or alcohol abuse

研究组 & 干预措施

PD patients visiting clinic

Experimental

All patients will undergo a NeuraLight session for oculometric evaluation along with eye-tracking recordings. All assessments will be performed during a clinic visit unless authorized to be conducted remotely.

干预措施: NeuraLight software-based platform (Other)

Healthy subjects

Experimental

All patients will undergo a NeuraLight session for oculometric evaluation along with eye-tracking recordings. All assessments will be performed during a visit unless authorized to be conducted remotely.

干预措施: NeuraLight software-based platform (Other)

结局指标

主要结局

Correlation between MDS-UPDRS score and its parts with NeuraLight oculometric measurements

时间窗: 12 months

The correlation between MDS-UPDRS score and its parts with NeuraLight oculometric measurements (R-Square\>0.5, p\<0.05) according to the Movement Disorder Society-Sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS) at every visit

Comparison of NeuraLight extracted oculometric measures with a validated eye-tracking system

时间窗: 12 months

Relative root mean square error (RMSE) of NeuraLight's extracted oculometric measures compared with retrieved measurements from a validated eye tracking system \<0.1

Feasibility of using NeuraLight system to capture oculometric measures in a cohort of PD patients and healthy subjects

时间窗: 12 months

Capturing \>50 different oculometric measures in \>95% of a cohort of about 1000 patients

次要结局

  • Using the retrieved data of collected NeuraLight oculometric measures for calibration of prediction models of MDS-UPDRS clinical endpoint(12 months)

研究者

发起方
NeuraLight
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验